Pathogenetic AQP4-IgG is responsible for more than 80% of NMO cases (5), while approximately 10–40% of individuals with NMO lack AQP4-IgG and instead exhibit pathogenetic MOG-IgG (6). This evidence concerns the gene AQP4 and neuromyelitis optica.